Lv11
48 积分 2021-04-22 加入
Top advances of the year: Small cell lung cancer
7小时前
待确认
Small cell lung cancer: Subtypes and therapeutic implications
2天前
已完结
B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy
11天前
已完结
Integrated transcriptomics and proteomics data analysis identifies CDH17 as a key cell surface target in colorectal cancer
1个月前
已完结
Progress in second-line antibody therapies for advanced esophageal squamous cell carcinoma
2个月前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
2个月前
已完结
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
2个月前
已完结
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
7个月前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
7个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
7个月前
已完结
皖公网安备34019202002308
